Delivery Order SPE2DB20D3103-SPE2DB23FM7C2
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,090.70, is for the procurement of 4557849085 ! SOL IV 0.9% NACL 100ML PLS CNTNR VFLX LF, a medical product. The award is not designated with a set-aside and was made through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, with a ceiling value of $2,205.44, is for the delivery of 4562720248 ! SOL IV 0.9% NACL 500ML PLS CNTNR VFLX LF medical supplies. The contract has an ultimate completion date of November 7, 2023 and is a Delivery Order under a Firm Fixed Price contract type. There is no set-aside designation, indicating the...
- This federal contract award, valued at $1,393.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00 through December 2025. The delivery order covers the supply of 4559181516 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL, a medical...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,811.42 firm fixed-price delivery order is for the supply of a medical product, specifically 4565800881 ! SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a...
- This federal contract award, valued at $2,894.88, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order for 4564145882 - SOL IV 0.9% NACL 100ML PH 5 PLS CNTNR. The contract has an ultimate completion date of April 3, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has also been awarded an indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of sodium chloride 0.9% solution 100ml. The contract, valued at $1,834.41, is a firm fixed-price delivery order without any set-aside designations. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- This federal contract award, valued at $1,998.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract covers the delivery of 4563248304 units of SOL IV 0.9% NACL 50ML 1 DS PWDR DRG VL, a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,323.00 for the supply of 0.9% sodium chloride (IV) solution in 100 mL plastic flex containers. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of May 12, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,398.38 firm-fixed-price contract is for the supply of 0.9% sodium chloride solution in 100 ml containers. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide pharmaceutical...
- This federal contract award, identified as SPE2DX15D3112|SPE2DX25FDZKB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,032.60 and an ultimate completion date of May 6, 2025. The contract is for the procurement of 4568138142 ! SOL IV 0.9% NACL 500ML PLS CNTNR VFLX LF, a medical supply item. This award is not designated as a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM7C2Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $2,668.35, is for the supply of 4560208169 - SOL IV 0.9% NACL 100ML PLS CNTNR VFLX LF, a medical product. There is no set-aside designation, indicating this was an open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000 respectively. These IDCs enable the company to efficiently supply a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs, including those for the military and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/9/23 |